Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy

BJU International

Volumn 112, Issue 4, 2013, Pages 453-461

  Xylinas, Evanguelos ^a,e   Rink, Michael ^a,g   Margulis, Vitaly ^b   Clozel, Thomas ^a   Lee, Richard K ^a   Comploj, Evi ^h   Novara, Giacomo ⁱ   Raman, Jay D ^c   Lotan, Yair ^b   Weizer, Alon ^d   Roupret, Morgan ^a,f   Pycha, Armin ^h   Scherr, Douglas S ^a   Seitz, Christian ^k   Ficarra, Vincenzo ⁱ   Trinh, Quoc Dien ^l   Karakiewicz, Pierre I ^l   Montorsi, Francesco ^j   Zerbib, Marc ^e   Shariat, Shahrokh F ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e Institut Cochin   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h CENTRAL HOSPITAL OF BOLZANO   (Italy)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^k MEDICAL UNIVERSITY OF VIENNA   (Austria)

^l UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

chemotherapy; radical nephroureterectomy; renal function; upper tract urothelial carcinoma

Indexed keywords

CISPLATIN; CREATININE;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROURETERECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADICAL NEPHROURETERECTOMY; TRANSITIONAL CELL CARCINOMA;

CHEMOTHERAPY; RADICAL NEPHROURETERECTOMY; RENAL FUNCTION; UPPER TRACT UROTHELIAL CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; PATIENT SELECTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; URETER;

EID: 84880829926     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11649.x     Document Type: Article

References (30)

1. Rouprêt M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 2011; 59: 584-594
2. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224-1233
3. Roscigno M, Shariat SF, Margulis V, et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 2009; 181: 2482-2489
4. Abouassaly R, Alibhai SM, Shah N, Timilshina N, Fleshner N, Finelli A,. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology 2010; 76: 895-901
5. Kwak C, Lee SE, Jeong IG, Ku JH,. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 2006; 68: 53-57
6. Hellenthal NJ, Shariat SF, Margulis V, et al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol 2009; 182: 900-906
7. Vassilakopoulou M, de la Motte Rouge T, Colin P, et al. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study. Cancer 2011; 117: 5500-5508
8. Lane BR, Smith AK, Larson BT, et al. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 2010; 116: 2967-2973
9. Kaag MG, O'Malley RL, O'Malley P, et al. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 2010; 58: 581-587
10. Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008; 179: 468-471
11. Greene FL, Balch CM, Fleming ID, et al. AJCC Cancer Staging Handbook: TNM Classification of Malignant Tumors, 6th edn. Chicago, IL: American Joint Committee on Cancer, 2002
12. Epstein JI, Amin MB, Reuter VR, Mostofi FK,. The World Health Organization / International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435-1448
13. Remzi M, Haitel A, Margulis V, et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 2009; 103: 307-311
14. Novara G, Matsumoto K, Kassouf W, et al. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 2010; 57: 1064-1071
15. Zigeuner R, Shariat SF, Margulis V, et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 2010; 57: 575-581
16. Raman JD, Ng CK, Scherr DS, et al. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 2010; 57: 1072-1079
17. Ouzzane A, Colin P, Xylinas E, et al. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol 2011; 60: 1258-1265
18. Chromecki TF, Cha EK, Fajkovic H, et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 2012; 61: 245-253
19. Rink M, Fajkovic H, Cha EK, et al. Death Certificates Are Valid for the Determination of Cause of Death in Patients With Upper and Lower Tract Urothelial Carcinoma. Eur Urol 2012; 61: 854-855
20. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
21. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
22. Shikanov S, Clark MA, Raman JD, et al. Chronic Kidney Disease Epidemiology Collaboration versus Modification of Diet in Renal Disease equations for renal function evaluation in patients undergoing partial nephrectomy. J Urol 2010; 184: 1867-1871
23. Chromecki TF, Bensalah K, Remzi M, et al. Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol 2011; 8: 440-447
24. Matin SF, Margulis V, Kamat A, et al. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 2010; 116: 3127-3134
25. Rajput MZ, Kamat AM, Clavell-Hernandez J, et al. Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy. Urology 2011; 78: 61-67
26. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005; 48: 202-205
27. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005; 48: 189-199
28. Castro AF, Coresh J,. CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 2009; 53: 46-55
29. Patard JJ, Pantuck AJ, Crepel M, et al. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol 2007; 52: 148-154
30. Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011; 59: 543-552